Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Phase 2 Clinical Trial to Evaluate OC-01 Nasal Spray in Subjects With Neurotrophic Keratopathy

ClinicalTrials.gov ID: NCT04957758

Public ClinicalTrials.gov record NCT04957758. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:54 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Controlled, Double-Masked, Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray in Subjects With Neurotrophic Keratopathy (the Olympia Study)

Study identification

NCT ID
NCT04957758
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Oyster Point Pharma, Inc.
Industry
Enrollment
113 participants

Conditions and interventions

Interventions

  • OC-01 (varenicline) nasal spray 1.2 mg/ml Drug
  • Placebo (vehicle) nasal spray Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 16, 2021
Primary completion
Jan 26, 2023
Completion
Apr 27, 2023
Last update posted
May 6, 2024

2021 – 2023

United States locations

U.S. sites
31
U.S. states
18
U.S. cities
30
Facility City State ZIP Site status
Dothan Alabama Dothan Alabama 36301
Irvine, California Irvine California 92697
Los Angeles California Los Angeles California 90095
Mission Hills California Mission Hills California 91345
Aurora Colorado Aurora Colorado 80045
Littleton, Colorado Littleton Colorado 80120
Longmont, Colorado Longmont Colorado 80503
Danbury, Connecticut Danbury Connecticut 06810
Brandon Florida Brandon Florida 33511
Brandon, Florida Brandon Florida 33511
Jacksonville Florida Jacksonville Florida 32256
Miami Florida Miami Florida 33136
Atlanta, Georgia Atlanta Georgia 30339
Hoffman Estates, Illinois Hoffman Estates Illinois 60169
Urbana Illinois Urbana Illinois 61801
Union Kentucky Edgewood Kentucky 41017
Louisville KY Louisville Kentucky 40206
Bowie, Maryland Bowie Maryland 20716
Boston Massachusetts Boston Massachusetts 02114
Kansas City Missouri Kansas City Missouri 64111
Henderson Nevada Henderson Nevada 89052
Bloomfield, New Jersey Bloomfield New Jersey 07003
Dover New Jersey Dover New Jersey 07801
Babylon New York Babylon New York 11702
New York NY New York New York 10029
York, Pennsylvania York Pennsylvania 17408
Houston Texas Houston Texas 77030
Katy, Texas Katy Texas 77494
San Antonio Texas San Antonio Texas 78229
Lynchburg Virginia Lynchburg Virginia 24502
Seattle Washington Seattle Washington 98119

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04957758, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 6, 2024 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04957758 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →